-transparent.png){kind=logo}
Use of clozapine is attended with the serious though rare risk of agranulocytosis. Clozapineinduced agranulocytosis is reversible with the use of cytokines like granulocyte-colony stimulating factor (G-CSF). Reports of the haematological complication of clozapine have not been forthcoming from India though it has been in use for nearly three years. This report is on an young patient who developed total absence of granulocytes during the 4th month of treatment who was successfully treated with G-CSF.
| UI | MeSH Term | Description | Entries |
|---|
Related Publications
T N Srinivasan, and
K Thomas
September 1994,
The Journal of clinical psychiatry,
T N Srinivasan, and
K Thomas
June 2016,
The American journal of psychiatry,
T N Srinivasan, and
K Thomas
March 1994,
Psychiatrische Praxis,
T N Srinivasan, and
K Thomas
April 1992,
British journal of haematology,
T N Srinivasan, and
K Thomas
March 2020,
Actas espanolas de psiquiatria,
T N Srinivasan, and
K Thomas
August 1994,
Sangre,
T N Srinivasan, and
K Thomas
June 1996,
Canadian journal of psychiatry. Revue canadienne de psychiatrie,
T N Srinivasan, and
K Thomas
January 1996,
Psychopharmacology bulletin,
T N Srinivasan, and
K Thomas
January 2001,
Hematology (Amsterdam, Netherlands),
T N Srinivasan, and
K Thomas
March 1993,
The American journal of psychiatry,
